American Journal of Cardiology
Volume 106, Issue 3 , Pages 342-347 , 1 August 2010

Impact of Multivessel Coronary Artery Disease and Noninfarct-Related Artery Revascularization on Outcome of Patients With ST-Elevation Myocardial Infarction Transferred for Primary Percutaneous Coronary Intervention (from the EUROTRANSFER Registry)

  • Artur Dziewierz, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University, Medical College, Krakow, Poland
    • ,
  • Zbigniew Siudak, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University, Medical College, Krakow, Poland
    • ,
  • Tomasz Rakowski, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University, Medical College, Krakow, Poland
    • ,
  • Wojciech Zasada, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University, Medical College, Krakow, Poland
    • ,
  • Jacek S. Dubiel, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University, Medical College, Krakow, Poland
    • ,
  • Dariusz Dudek, MD

      Affiliations

    • Department of Interventional Cardiology, Jagiellonian University, Medical College, Krakow, Poland
    • Corresponding Author InformationCorresponding author: Tel: 48-12-424-71-81; fax: 48-12-424-71-84

Received 25 January 2010 ,Revised 22 March 2010 ,Accepted 22 March 2010.

References 

  1. Jaski BE, Cohen JD, Trausch J, Marsh DG, Bail GR, Overlie PA, et al. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. Am Heart J. 1992;124:1427–1433
  2. Moreno R, Garcia E, Elizaga J, Abeytua M, Soriano J, Botas J, et al. Results of primary angioplasty in patients with multivessel disease. Rev Esp Cardiol. 1998;51:547–555
  3. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28:1709–1716
  4. Xu F, Chen YG, Li JF, Li GS, Ji QS, Lv RJ, et al. Multivessel percutaneous coronary intervention in Chinese patients with acute myocardial infarction and simple nonculprit arteries. Am J Med Sci. 2007;333:376–380
  5. Hanratty CG, Koyama Y, Rasmussen HH, Nelson GI, Hansen PS, Ward MR. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. J Am Coll Cardiol. 2002;40:911–916
  6. van der Schaaf RJ, Vis MM, Sjauw KD, Koch KT, Baan J, Tijssen JG, et al. Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion. Am J Cardiol. 2006;98:1165–1169
  7. van der Schaaf RJ, Timmer JR, Ottervanger JP, Hoorntje JC, de Boer MJ, Suryapranata H, et al. Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart. 2006;92:1760–1763
  8. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909–2945
  9. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 (Writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee). Circulation. 2008;117:296–329
  10. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110(suppl):e82–e292
  11. Di Mario C, Sansa M, Airoldi F, Sheiban I, Manari A, Petronio A, et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) study. Int J Cardiovasc Interv. 2004;6:128–133
  12. Ochala A, Smolka GA, Wojakowski W, Dudek D, Dziewierz A, Krolikowski Z, et al. The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction. J Invasive Cardiol. 2004;16:699–702
  13. Politi L, Sgura F, Rossi R, Monopoli D, Guerri E, Leuzzi C, et al. Multivessel coronary disease in ST-elevation myocardial infarction: three different revascularization strategies and long-term outcomes. Heart. 2009;96:662–667
  14. Qarawani D, Nahir M, Abboud M, Hazanov Y, Hasin Y. Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol. 2008;123:288–292
  15. Khattab AA, Abdel-Wahab M, Rother C, Liska B, Toelg R, Kassner G, et al. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction (A single-center experience). Clin Res Cardiol. 2008;97:32–38
  16. Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol. 2009;104:507–513
  17. Corpus RA, House JA, Marso SP, Grantham JA, Huber KC, Laster SB, et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J. 2004;148:493–500
  18. Roe MT, Cura FA, Joski PS, Garcia E, Guetta V, Kereiakes DJ, et al. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol. 2001;88:170–173A6
  19. Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, et al. European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab—EUROTRANSFER Registry. Am Heart J. 2008;156:1147–1154
  20. Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Legutko J, Mielecki W, et al. Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile (Results from EUROTRANSFER registry). Am Heart J. 2009;158:569–575
  21. Muller DW, Topol EJ, Ellis SG, Sigmon KN, Lee K, Califf RM. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction (Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group). Am Heart J. 1991;121:1042–1049
  22. Dudek D, Chyrchel B, Siudak Z, Depukat R, Chyrchel M, Dziewierz A, et al. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score. Kardiol Pol. 2008;66:28–34
  23. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van't Hof AW, Hoorntje JC, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J. 2002;23:1112–1117
  24. Napodano M, Ramondo A, Tarantini G, Peluso D, Compagno S, Fraccaro C, et al. Predictors and time-related impact of distal embolization during primary angioplasty. Eur Heart J. 2009;30:305–313

 The EUROTRANSFER Registry was an academic research project supported by a research grant from Eli Lilly and Company, Critical Care Europe, Geneva, Switzerland.

PII: S0002-9149(10)00778-2

doi: 10.1016/j.amjcard.2010.03.029

American Journal of Cardiology
Volume 106, Issue 3 , Pages 342-347 , 1 August 2010

Article Tools

* Image Usage & Resolution